Literature DB >> 20002453

Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation-positive families?

S Panchal1, L Bordeleau, A Poll, M Llacuachaqui, O Shachar, P Ainsworth, S Armel, A Eisen, P Sun, S A Narod.   

Abstract

Women who carry BRCA mutations are advised to begin breast cancer screening based on the age-specific risks of breast cancer development. It is not clear to what extent the family history of breast cancer influences age of onset. We evaluated the use of family history to predict the age of breast cancer onset in BRCA mutation carriers. Pedigrees from an Ontario-based registry were reviewed to identify the index case of breast cancer (most recent diagnosis) and other family cases of breast cancer. The youngest age of breast cancer diagnosis and mean age at breast cancer diagnosis in the other family cases were compared to the age of onset in the index case. The 260 BRCA1 and 213 BRCA2 pedigrees were reviewed. In BRCA2 families, the index case was diagnosed on average at 44.4 years when the youngest reported family case was less than or equal to 35 years, compared to 51.9 years when the earliest cases were diagnosed after age 50 (p = 0.04). A modest trend was seen for BRCA1 carriers, but this was not statistically significant. To a small extent, the onset of breast cancer in a BRCA2 mutation carrier can be predicted from her family history of cancer, however, the trend is modest and should not alter clinical recommendations regarding initiation of screening.

Entities:  

Mesh:

Year:  2009        PMID: 20002453     DOI: 10.1111/j.1399-0004.2009.01328.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment.

Authors:  Vidhya Hariharan; Timothy Toole; Jared Klarquist; Jeffrey Mosenson; B Jack Longley; I Caroline Le Poole
Journal:  Melanoma Res       Date:  2011-04       Impact factor: 3.599

Review 2.  Management of genetic syndromes predisposing to gynecologic cancers.

Authors:  Susan Miesfeldt; Amanda Lamb; Christine Duarte
Journal:  Curr Treat Options Oncol       Date:  2013-03

3.  Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family.

Authors:  Ieva Sadzevičienė; Sonata Jarmalaitė; Justinas Besusparis; Olga Liaugaudienė; Jolita Asadauskienė; Birutė Brasiūnienė; Ilona Kulikienė; Rasa Sabaliauskaitė
Journal:  Medicina (Kaunas)       Date:  2020-03-10       Impact factor: 2.430

4.  Public health in the genomic era: will Public Health Genomics contribute to major changes in the prevention of common diseases?

Authors:  Evy Cleeren; Johan Van der Heyden; Angela Brand; Herman Van Oyen
Journal:  Arch Public Health       Date:  2011-12-05

5.  No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families.

Authors:  Marion Imbert-Bouteille; Carole Corsini; Marie-Christine Picot; Lucas Mizrahy; Sandrine Akouete; Helena Huguet; Frédéric Thomas; David Geneviève; Patrice Taourel; Marc Ychou; Virginie Galibert; Chloé Rideau; Karen Baudry; Tatiana Kogut Kubiak; Isabelle Coupier; Rémy Hobeika; Yvette Macary; Alain Toledano; Jérôme Solassol; Antoine Maalouf; Jean-Pierre Daures; Pascal Pujol
Journal:  Genes (Basel)       Date:  2021-07-20       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.